Check-Cap Ltd. (NASDAQ:CHEK – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.59 and traded as low as $0.60. Check-Cap shares last traded at $0.60, with a volume of 16,599 shares traded.
Analysts Set New Price Targets
Separately, StockNews.com began coverage on shares of Check-Cap in a report on Thursday. They set a “sell” rating on the stock.
Get Our Latest Research Report on CHEK
Check-Cap Stock Down 1.8 %
About Check-Cap
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.
Further Reading
- Five stocks we like better than Check-Cap
- What is the S&P 500 and How It is Distinct from Other Indexes
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Canada Bond Market Holiday: How to Invest and Trade
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Bank Stocks – Best Bank Stocks to Invest In
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.